Genomic Center for Infectious Diseases Projects

The J. Craig Venter Institute (JCVI) Genomic Center for Infectious Diseases (GCID), now in its 14th year, was established by the National Institute for Allergy and Infectious Diseases (NIAID) to investigate infectious disease biology through the application of DNA sequencing, genotyping, and comparative genome analysis. The JCVI GCID aims to study pathogens and the genetic determinants of their virulence, drug-resistance, immune evasion and interactions with the host, and host microbiome to advance research in pathogenicity, drug-resistance, disease transmission and vaccine development. The JCVI center is organized into three research projects broadly studying viral, bacterial, and parasitic pathogens.

Genomic Center for Infectious Diseases Projects

The J. Craig Venter Institute (JCVI) Genomic Center for Infectious Diseases (GCID), now in its 14th year, was established by the National Institute for Allergy and Infectious Diseases (NIAID) to investigate infectious disease biology through the application of DNA sequencing, genotyping, and comparative genome analysis. The JCVI GCID aims to study pathogens and the genetic determinants of their virulence, drug-resistance, immune evasion and interactions with the host, and host microbiome to advance research in pathogenicity, drug-resistance, disease transmission and vaccine development. The JCVI center is organized into three research projects broadly studying viral, bacterial, and parasitic pathogens.

You are here